FIELD: medicine.
SUBSTANCE: group of inventions relates to the field of medicine, namely to an application of a compound by Formula 1 as an active ingredient of a medicinal product for prevention or treatment of spinal cord injury
Formula 1
,
and also relates to a method for preventing or treating spinal cord injury comprising administering a substance to a subject orally or parenterally the active ingredient whereof is a compound represented by Formula 1 in doses of 1 to 1000 mg/kg per day in portions throughout the day.
EFFECT: group of inventions provides preparation of a composition containing a compound (S)-2-(((4'-trifluoromethylbiphenyl-4-yl)methyl)amino)propanamide methane sulfonate or a pharmaceutically acceptable salt thereof, wherein the composition has an excellent effect on preventing, alleviating the consequences and treating spinal cord injury by regenerating the nerve function deterioration caused by spinal cord injury, alleviating pain and facilitating regeneration of the damaged spinal cord tissue.
7 cl, 2 ex, 11 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| COMPOSITION FOR PREVENTING OR TREATING A STROKE | 2019 |
|
RU2765151C1 |
| PHARMACEUTICAL COMPOSITION FOR INHIBITING NEURONAL APOPTOSIS OR NEURODEGENERATION | 2011 |
|
RU2586772C2 |
| NEUROTROPIC TACROLIMUS ANALOGS | 2001 |
|
RU2288716C2 |
| PHARMACEUTICAL COMPOSITION FOR INHIBITING APOPTOSIS OF NEURONS OR NEURODEGENERATION | 2011 |
|
RU2722018C2 |
| PHARMACEUTICAL COMPOSITION FOR PREVENTION OR TREATMENT OF PERIODONTOSIS OR TRAUMATIC TOOTH DISLOCATION | 2021 |
|
RU2811919C1 |
| NEW PEPTIDE | 2018 |
|
RU2764770C1 |
| NEW PEPTIDE | 2017 |
|
RU2719434C1 |
| NEW PREVENTIVE AND/OR THERAPEUTIC AGENT FOR NEUROPATHIC PAIN | 2008 |
|
RU2462459C2 |
| PHARMACEUTICAL COMPOSITION FOR PREVENTION OR TREATMENT OF NON-ALCOHOLIC STEATHOEPATITIS | 2021 |
|
RU2803733C1 |
| PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING NON-ALCOHOLIC FATTY LIVER INFILTRATION, CONTAINING GPR119 LIGAND AS ACTIVE INGREDIENT | 2019 |
|
RU2768943C1 |
